Abbott Healthcare Products Limited

Solvay Healthcare, Mansbridge Road, West End, Southampton, SO18 3JD
Telephone: +44 (0)2380 467 000
Fax: +44 (0)2380 465 350
Medical Information e-mail: medinfo.shl@abbott.com
Customer Care direct line: +44 (0)1753 650 099
Medical Information Fax: +44 (0)2380 465 350

Patient Information Leaflet last updated on the eMC: 14/01/2011
PIL Froben Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/01/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 04/12/2008 and displayed until 14/01/2011
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/03/2008 and displayed until 04/12/2008
Reasons for adding or updating:
  • Change to name of manufacturer
  • Correction of spelling/typing errors
Updated on 24/04/2007 and displayed until 13/03/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change of contra-indications
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 18/04/2005 and displayed until 24/04/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 15/11/2002 and displayed until 18/04/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   flurbiprofen